Fotios Loupakis


Ontology type: schema:Person     


Person Info

NAME

Fotios

SURNAME

Loupakis

Publications in SciGraph latest 50 shown

  • 2019-12 Shared heritability and functional enrichment across six solid cancers in NATURE COMMUNICATIONS
  • 2019-02 Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies in DRUG SAFETY
  • 2019-02 Safety and Tolerability of c-MET Inhibitors in Cancer in DRUG SAFETY
  • 2019-01-28 Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib in THE PHARMACOGENOMICS JOURNAL
  • 2018-12 Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases in CANCER CELL INTERNATIONAL
  • 2018-12 Impact of primary tumour location on efficacy of bevacizumab plus chemotherapy in metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2018-12 Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy in NATURE COMMUNICATIONS
  • 2018-12 The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients in BMC CANCER
  • 2018-09 Potential role of PIN1 genotypes in predicting benefit from oxaliplatin-based and irinotecan-based treatment in patients with metastatic colorectal cancer in THE PHARMACOGENOMICS JOURNAL
  • 2018-08 Pharmacokinetic analysis of metronomic capecitabine in refractory metastatic colorectal cancer patients in INVESTIGATIONAL NEW DRUGS
  • 2017-12 TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group in BMC CANCER
  • 2017-12 CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy in THE PHARMACOGENOMICS JOURNAL
  • 2017-07 Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab in THE PHARMACOGENOMICS JOURNAL
  • 2017-06 Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer in THE PHARMACOGENOMICS JOURNAL
  • 2017-01 Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2016-07 Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients in SCIENTIFIC REPORTS
  • 2016-06 A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer in TARGETED ONCOLOGY
  • 2016-01 Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2015-12 Molecular and pathological characterization of the EZH2 rs3757441 single nucleotide polymorphism in colorectal cancer in BMC CANCER
  • 2015-12 BRAF-mutated metastatic colorectal cancer between past and future in BRITISH JOURNAL OF CANCER
  • 2015-11 Assessment of a HER2 scoring system for colorectal cancer: results from a validation study in MODERN PATHOLOGY
  • 2015-10 First-line chemotherapy for mCRC—a review and evidence-based algorithm in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2015-08 Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy in THE PHARMACOGENOMICS JOURNAL
  • 2015-07 Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients in NATURE MEDICINE
  • 2015-07 Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients in NATURE MEDICINE
  • 2015-06 BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection in BRITISH JOURNAL OF CANCER
  • 2015-06 Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer in THE PHARMACOGENOMICS JOURNAL
  • 2015-06 Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer in THE PHARMACOGENOMICS JOURNAL
  • 2015-02 Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer in THE PHARMACOGENOMICS JOURNAL
  • 2014-09 EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan in TARGETED ONCOLOGY
  • 2014-08 Prospective study of EGFR intron 1 (CA)n repeats variants as predictors of benefit from cetuximab and irinotecan in chemo-refractory metastatic colorectal cancer (mCRC) patients in THE PHARMACOGENOMICS JOURNAL
  • 2014-04 Gender-specific profiling in SCN1A polymorphisms and time-to-recurrence in patients with stage II/III colorectal cancer treated with adjuvant 5-fluoruracil chemotherapy in THE PHARMACOGENOMICS JOURNAL
  • 2014-04 Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence in THE PHARMACOGENOMICS JOURNAL
  • 2014-02 Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy in THE PHARMACOGENOMICS JOURNAL
  • 2014-02 A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy in EPMA JOURNAL
  • 2014 The Role of Metronomic Chemotherapy in the Treatment of Metastatic Colorectal Cancer Patients in METRONOMIC CHEMOTHERAPY
  • 2013-12 Reply: Comment on ‘Histopathologic evaluation of liver metastases from colorectal cancer patients treated with FOLFOXIRI plus bevacizumab’ in BRITISH JOURNAL OF CANCER
  • 2013-08 Liquid biopsy: monitoring cancer-genetics in the blood in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2013-06 Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab in BRITISH JOURNAL OF CANCER
  • 2012-12 Pharmacogenetic Concerns in Metastatic Colorectal Cancer Therapy in CURRENT COLORECTAL CANCER REPORTS
  • 2012-09 Selecting the best targeted agent in first-line treatment of unresectable liver metastases from colorectal cancer: does the bench have the answers? in JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
  • 2012-09 Upfront Chemotherapy Regimens in Unresectable Disease: One, Two, or Three Cytotoxics? in CURRENT COLORECTAL CANCER REPORTS
  • 2012-07 Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2012-06 Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers in ANGIOGENESIS
  • 2011-12 Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer in BMC CANCER
  • 2011-05 Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients in BRITISH JOURNAL OF CANCER
  • 2011-04 Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer in BRITISH JOURNAL OF CANCER
  • 2010-12 Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials in JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
  • 2010-10 Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan in THE PHARMACOGENOMICS JOURNAL
  • 2010-08 Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.419546.b", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.24704.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417520.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415103.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7010.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.12711.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5395.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.488566.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.42505.36", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.29980.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.460094.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9657.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.4527.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.144189.1", 
            "type": "Organization"
          }
        ], 
        "familyName": "Loupakis", 
        "givenName": "Fotios", 
        "id": "sg:person.01175106504.32", 
        "identifier": {
          "name": "orcid_id", 
          "type": "PropertyValue", 
          "value": [
            "0000-0001-9651-0395"
          ]
        }, 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175106504.32", 
          "https://orcid.org/0000-0001-9651-0395"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:44", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_482.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01175106504.32'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01175106504.32'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01175106504.32'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01175106504.32'


     

    This table displays all metadata directly associated to this object as RDF triples.

    47 TRIPLES      11 PREDICATES      26 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01175106504.32 schema:affiliation N34d032e305cf4ab1adcea629bc26d8dc
    2 https://www.grid.ac/institutes/grid.12711.34
    3 https://www.grid.ac/institutes/grid.144189.1
    4 https://www.grid.ac/institutes/grid.24704.35
    5 https://www.grid.ac/institutes/grid.29980.3a
    6 https://www.grid.ac/institutes/grid.415103.2
    7 https://www.grid.ac/institutes/grid.417520.5
    8 https://www.grid.ac/institutes/grid.42505.36
    9 https://www.grid.ac/institutes/grid.4527.4
    10 https://www.grid.ac/institutes/grid.460094.f
    11 https://www.grid.ac/institutes/grid.488566.1
    12 https://www.grid.ac/institutes/grid.5395.a
    13 https://www.grid.ac/institutes/grid.7010.6
    14 https://www.grid.ac/institutes/grid.9657.d
    15 schema:familyName Loupakis
    16 schema:givenName Fotios
    17 schema:identifier N5afff7b4a1c04bf588d57b2c6fc40978
    18 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01175106504.32
    19 https://orcid.org/0000-0001-9651-0395
    20 schema:sdDatePublished 2019-03-07T14:44
    21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    22 schema:sdPublisher Nd4dc79c9b36d429a954ccff58964035c
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset persons
    25 rdf:type schema:Person
    26 N34d032e305cf4ab1adcea629bc26d8dc schema:affiliation https://www.grid.ac/institutes/grid.419546.b
    27 sgo:isCurrent true
    28 rdf:type schema:OrganizationRole
    29 N5afff7b4a1c04bf588d57b2c6fc40978 schema:name orcid_id
    30 schema:value 0000-0001-9651-0395
    31 rdf:type schema:PropertyValue
    32 Nd4dc79c9b36d429a954ccff58964035c schema:name Springer Nature - SN SciGraph project
    33 rdf:type schema:Organization
    34 https://www.grid.ac/institutes/grid.12711.34 schema:Organization
    35 https://www.grid.ac/institutes/grid.144189.1 schema:Organization
    36 https://www.grid.ac/institutes/grid.24704.35 schema:Organization
    37 https://www.grid.ac/institutes/grid.29980.3a schema:Organization
    38 https://www.grid.ac/institutes/grid.415103.2 schema:Organization
    39 https://www.grid.ac/institutes/grid.417520.5 schema:Organization
    40 https://www.grid.ac/institutes/grid.419546.b schema:Organization
    41 https://www.grid.ac/institutes/grid.42505.36 schema:Organization
    42 https://www.grid.ac/institutes/grid.4527.4 schema:Organization
    43 https://www.grid.ac/institutes/grid.460094.f schema:Organization
    44 https://www.grid.ac/institutes/grid.488566.1 schema:Organization
    45 https://www.grid.ac/institutes/grid.5395.a schema:Organization
    46 https://www.grid.ac/institutes/grid.7010.6 schema:Organization
    47 https://www.grid.ac/institutes/grid.9657.d schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...